|
⚲
|
| Keyboard |
| Wrv GP II LLC | |
|---|---|
| Firm | MNS Global Capital Managers LLC |
| Address | c/o Maples Corporate Services Limited Ugland House, PO Box 309 Grand Cayman, E9 KY1-1104 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| MNS Global Capital Managers LLC | |||||
| Celesta Capital II LP | 021-240539 | Promoter | of 325.0 M |
154.5 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bruker Cellular Analysis Inc BLI
Common Stock
|
2021-01-12 | Other | 12,276,309 | $0.00 | |
|
Bruker Cellular Analysis Inc BLI
Common Stock
|
2020-12-10 | Sell | 183,018 | $82.56 | 15,109,966 |
|
Bruker Cellular Analysis Inc BLI
Common Stock
|
2020-11-23 | Sell | 1,203,029 | $82.56 | 99,322,074 |
|
Bruker Cellular Analysis Inc BLI
Series C Preferred Stock · derivative
|
2020-07-16 | Conversion | 2,812,029 | $0.00 | |
|
Bruker Cellular Analysis Inc BLI
Common Stock
|
2020-07-16 | Conversion | 13,662,357 | ||
|
Bruker Cellular Analysis Inc BLI
Series B Preferred Stock · derivative
|
2020-07-16 | Conversion | 8,406,337 | $0.00 | |
|
Bruker Cellular Analysis Inc BLI
Series E Preferred Stock · derivative
|
2020-07-16 | Conversion | 735,635 | $0.00 | |
|
Bruker Cellular Analysis Inc BLI
Series D Preferred Stock · derivative
|
2020-07-16 | Conversion | 1,708,356 | $0.00 |